Omeros

Omeros terminates kidney disease trial as therapy fails in late-stage study
Reuters
Mon, 10/16/23 - 10:15 am
Omeros
kidney disease
clinical trials
narsoplimab
Berger's disease
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Aldeyra Therapeutics
Autolus Therapeutics
Bavarian Nordic
BioXcel Therapeutics
Disc Medicine
Editas Medicine
Immunogen
Lantheus
Mersana Therapeutics
NGM Biopharmaceuticals
Omeros
Roche
Sutro BioPharma
uniQure
Valneva
Viking Therapeutics
After rejection and appeal, Omeros saddles up for 2nd charge at transplant drug approval
BioSpace
Tue, 03/14/23 - 10:59 am
Omeros
transplant-associated thrombotic microangiopathy
organ transplants
narsoplimab
Omeros' Hail Mary throw for blood clot med application delayed at FDA
Fierce Biotech
Wed, 08/17/22 - 12:12 pm
Omeros
FDA
narsoplimab
A Seattle biotech offloads lead eye drug in deal valued at $1B+ as it refocuses on emerging pipeline
Endpoints
Thu, 12/2/21 - 11:00 am
Omeros
Omidria
cataract surgery
post-operative pain
Rayner Surgical
FDA rejects Omeros transplant drug over difficulties estimating its effect
Fierce Biotech
Mon, 10/18/21 - 11:14 am
FDA
organ transplant
stem cells
Omeros
Omeros Reports Coronavirus Treatment Success; Stock Soars
Investors Business Daily
Mon, 08/10/20 - 10:58 am
Omeros
clinical trials
COVID-19
narsoplimab
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Wed, 12/4/19 - 09:58 am
Omeros
narsoplimab
stem cells
stem cell transplant
clinical trials
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
CP Wire
Tue, 10/23/18 - 11:00 pm
Omeros
OMS721
stem cells
thrombotic microangiopathy
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
Tue, 10/23/18 - 09:43 am
Omeros
OMS721
stem cell
thrombotic microangiopathy
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
CP Wire
Wed, 08/29/18 - 10:26 am
Omeros
OMS721
thrombotic microangiopathy
Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
Tue, 08/28/18 - 11:53 am
Omeros
OMS721
thrombotic microangiopathy
Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Thu, 07/26/18 - 11:24 am
Omeros
Sandoz
Novartis
patents
Omidria
Omeros Prevails in Patent Dispute With Sandoz
Thu, 07/26/18 - 09:12 am
Omeros
Omidria
Sandoz
lawsuits
patent lawsuits
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
TheStreet.com
Fri, 03/23/18 - 09:50 am
Big Pharma
Medicare Part D
Omeros
Omnibus Bill
5 Small Biotechs Receive Shots in the Arm
TheStreet.com
Mon, 11/13/17 - 09:22 am
earnings
Synergy Pharmaceuticals
Omeros
BioDelivery Sciences
Heron Therapeutics
Dynavax
Omeros defends its drug, but still won’t answer basic questions
Stat
Wed, 08/23/17 - 10:19 pm
Omeros
OMS721
These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing?
Motley Fool
Tue, 06/27/17 - 11:52 pm
biotech
Omeros
Cara Therapeutics
Portola Pharmaceuticals
Biotech Movers: OncoMed, Incyte, Omeros
TheStreet.com
Mon, 04/17/17 - 11:22 am
biotech
OncoMed
tarextumab
small cell lung cancer
Incyte
Eli Lilly
baricitinib
Omeros

Pages